7Baggers
 Immuneering CEO accelerates tumor treatment pipeline at BIO Europe  Traders Union Mon, 17 Nov 2025 20:15:48 GMT
 Immuneering (IMRX) Q3 2025 Earnings Transcript  AOL.com Sat, 15 Nov 2025 21:58:50 GMT
 Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript  Insider Monkey Fri, 14 Nov 2025 13:13:02 GMT
 Immuneering Corp. Shines in Positive Earnings Call  TipRanks Fri, 14 Nov 2025 00:37:50 GMT
 Immuneering: Atebimetinib MEK Inhibitor for Pancreatic Cancer  BioXconomy Thu, 13 Nov 2025 17:59:19 GMT
 immuneering (imrx) q3 2025 earnings transcript  The Motley Fool Thu, 13 Nov 2025 17:19:00 GMT
 Immuneering rises after smaller-than-expected Q3 loss  TradingView Thu, 13 Nov 2025 15:27:46 GMT
 Immuneering Corp. Reports Strong Q3 2025 Progress  TipRanks Thu, 13 Nov 2025 04:46:41 GMT
 immuneering corporation (imrx) tops q3 eps by 3c  StreetInsider Wed, 12 Nov 2025 23:48:51 GMT
 Immuneering reports Q3 EPS (38c), consensus (39c)  TipRanks Wed, 12 Nov 2025 21:58:07 GMT
 Immuneering reports smaller-than-expected Q3 net loss  MarketScreener Wed, 12 Nov 2025 21:32:04 GMT
 immuneering corporation (imrx) q3 fy2025 earnings call transcript  Yahoo Finance Wed, 12 Nov 2025 21:30:00 GMT
 immuneering (imrx) q3 2025 earnings transcript  The Globe and Mail Wed, 12 Nov 2025 21:30:00 GMT
 A Preview Of Immuneering's Earnings  Benzinga Tue, 11 Nov 2025 15:03:44 GMT
 are these 4 biotech stocks set to beat q3 earnings estimates?  TradingView Mon, 10 Nov 2025 16:21:00 GMT
 immuneering drives pancreas disease research at apa annual meeting  Traders Union Mon, 10 Nov 2025 06:55:53 GMT
 immuneering corporation (imrx) stock forecast and price target  Yahoo Finance UK Wed, 05 Nov 2025 12:49:55 GMT
 immuneering (imrx) expected to announce earnings on wednesday  MarketBeat Wed, 05 Nov 2025 12:09:00 GMT

Immuneering Corporation
(NASDAQ:IMRX) 

IMRX stock logo

Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.

Founded: 2008
CEO / Co-Founder: Ben Zeskind 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends